| Matthew Harrison Martell, DO | |
|
840 Pine St Ste 500, Macon, GA 31201-7530 | |
| (478) 633-8682 | |
| (478) 633-8698 |
| Full Name | Matthew Harrison Martell |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 840 Pine St Ste 500, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104269463 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Services Of Central Georgia | 9638076730 | 205 |
News Archive
Researchers of the University of Granada and Edinburgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.
Rift Valley fever virus, transmitted by mosquitoes, is responsible for outbreaks in livestock in Africa and can also be fatal in humans. Scientists from the Institut Pasteur and the CNRS, working with the University of Göttingen, have characterized the mechanism used by the virus to insert one of its envelope proteins into the host cell membrane, thereby enabling it to infect the cell.
WHO Regional Director for Africa Luis Gomes Sambo said Tuesday during the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, that measles could be eradicated from the continent by 2020, citing an 89 percent reduction in the number of deaths caused by measles between 2000 and 2007, Angencia AngolaPress reports.
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.
› Verified 8 days ago
| Entity Name | Health Services Of Central Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184679482 PECOS PAC ID: 9638076730 Enrollment ID: O20031217000270 |
News Archive
Researchers of the University of Granada and Edinburgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.
Rift Valley fever virus, transmitted by mosquitoes, is responsible for outbreaks in livestock in Africa and can also be fatal in humans. Scientists from the Institut Pasteur and the CNRS, working with the University of Göttingen, have characterized the mechanism used by the virus to insert one of its envelope proteins into the host cell membrane, thereby enabling it to infect the cell.
WHO Regional Director for Africa Luis Gomes Sambo said Tuesday during the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, that measles could be eradicated from the continent by 2020, citing an 89 percent reduction in the number of deaths caused by measles between 2000 and 2007, Angencia AngolaPress reports.
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Harrison Martell, DO 840 Pine St Ste 500, Macon, GA 31201-7530 Ph: (478) 633-8682 | Matthew Harrison Martell, DO 840 Pine St Ste 500, Macon, GA 31201-7530 Ph: (478) 633-8682 |
News Archive
Researchers of the University of Granada and Edinburgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.
Rift Valley fever virus, transmitted by mosquitoes, is responsible for outbreaks in livestock in Africa and can also be fatal in humans. Scientists from the Institut Pasteur and the CNRS, working with the University of Göttingen, have characterized the mechanism used by the virus to insert one of its envelope proteins into the host cell membrane, thereby enabling it to infect the cell.
WHO Regional Director for Africa Luis Gomes Sambo said Tuesday during the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, that measles could be eradicated from the continent by 2020, citing an 89 percent reduction in the number of deaths caused by measles between 2000 and 2007, Angencia AngolaPress reports.
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.
› Verified 8 days ago
Dr. Waldo Emerson Floyd Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3708 Northside Dr, Macon, GA 31210 Phone: 478-745-4206 Fax: 478-254-5463 | |
Ryan Edward Schnetzer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3708 Northside Dr, Macon, GA 31210 Phone: 478-254-5303 | |
Loren Jared Hudspeth, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 440 Charter Blvd Ste 3302, Macon, GA 31210 Phone: 478-200-5710 | |
Dr. Oluwatosin J Ojo, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3708 Northside Dr, Macon, GA 31210 Phone: 478-745-4206 Fax: 478-254-5303 | |
Dr. John Z. Chrabuszcz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3708 Northside Dr, Macon, GA 31210 Phone: 478-745-4206 Fax: 478-254-5463 | |
Dr. Jeffrey A Fried, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6501 Peake Rd, Bldg 400, Macon, GA 31210 Phone: 478-477-0966 Fax: 478-475-0084 |